01 6Gilead Sciences Canada Inc.
01 22470365
02 22566922
03 22847871
01 6Elvitegravir
01 6Tablet
01 22023-11-20
02 22025-05-19
03 22026-12-29
Patent Expiration Date : 2025-05-19
Date Granted : 2011-01-11
Brand Name : VITEKTA
Patent Number : 2566922
Filing Date : 2005-05-19
Strength per Unit : 85 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-05-19
Date Granted : 2011-01-11
Patent Expiration Date : 2023-11-20
Date Granted : 2011-05-17
Brand Name : VITEKTA
Patent Number : 2470365
Filing Date : 2003-11-20
Strength per Unit : 85 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-11-20
Date Granted : 2011-05-17
Patent Expiration Date : 2023-11-20
Date Granted : 2011-05-17
Brand Name : VITEKTA
Patent Number : 2470365
Filing Date : 2003-11-20
Strength per Unit : 150 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-11-20
Date Granted : 2011-05-17
Patent Expiration Date : 2025-05-19
Date Granted : 2011-01-11
Brand Name : VITEKTA
Patent Number : 2566922
Filing Date : 2005-05-19
Strength per Unit : 150 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-05-19
Date Granted : 2011-01-11
Patent Expiration Date : 2026-12-29
Date Granted : 2016-07-26
Brand Name : VITEKTA
Patent Number : 2847871
Filing Date : 2006-12-29
Strength per Unit : 85 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-12-29
Date Granted : 2016-07-26
Patent Expiration Date : 2026-12-29
Date Granted : 2016-07-26
Brand Name : VITEKTA
Patent Number : 2847871
Filing Date : 2006-12-29
Strength per Unit : 150 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-12-29
Date Granted : 2016-07-26
